Gonzalgo ML - Search Results

1

Use and Validation of the AUA/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort.

Ritch CR, Velasquez MC, Kwon D, Becerra MF, Soodana-Prakash N, Atluri VS, Almengo K, Alameddine M, Kineish O, Kava BR, Punnen S, Parekh DJ, Gonzalgo ML. Ritch CR, et al. Among authors: gonzalgo ml. J Urol. 2020 Mar;203(3):505-511. doi: 10.1097/JU.0000000000000593. Epub 2019 Oct 14. J Urol. 2020. PMID: 31609178

2

DNA methylation in bladder cancer.

Jones PA, Gonzalgo ML, Tsutsumi M, Bender CM. Jones PA, et al. Among authors: gonzalgo ml. Eur Urol. 1998;33 Suppl 4:7-8. doi: 10.1159/000052251. Eur Urol. 1998. PMID: 9615197 No abstract available.

3

Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.

Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML. Magheli A, et al. Among authors: gonzalgo ml. J Urol. 2007 Oct;178(4 Pt 1):1311-5. doi: 10.1016/j.juro.2007.05.143. Epub 2007 Aug 16. J Urol. 2007. PMID: 17698095

4

Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.

Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML. Magheli A, et al. Among authors: gonzalgo ml. J Urol. 2007 Oct;178(4 Pt 1):1277-80; discussion 1280-1. doi: 10.1016/j.juro.2007.05.153. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698121

5

Urethral carcinosarcoma from bladder carcinosarcomatous lesions: analysis of clinicopathological features.

Bivalacqua TJ, Bagga HS, Patil K, Magheli A, Taube JM, Guzzo TJ, Gonzalgo ML. Bivalacqua TJ, et al. Among authors: gonzalgo ml. Can J Urol. 2009 Feb;16(1):4512-5. Can J Urol. 2009. PMID: 19222894

6

Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.

Trock BJ, Guo CC, Gonzalgo ML, Magheli A, Loeb S, Epstein JI. Trock BJ, et al. Among authors: gonzalgo ml. J Urol. 2009 Oct;182(4):1364-70. doi: 10.1016/j.juro.2009.06.048. Epub 2009 Aug 14. J Urol. 2009. PMID: 19683280 Free PMC article.

7

Editorial comment.

Gonzalgo ML. Gonzalgo ML. J Urol. 2009 Oct;182(4):1311-2. doi: 10.1016/j.juro.2009.06.143. Epub 2009 Aug 14. J Urol. 2009. PMID: 19683285 No abstract available.

8

Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer.

Guzzo TJ, Magheli A, Bivalacqua TJ, Nielsen ME, Attenello FJ, Schoenberg MP, Gonzalgo ML. Guzzo TJ, et al. Among authors: gonzalgo ml. Urology. 2009 Dec;74(6):1276-80. doi: 10.1016/j.urology.2009.05.092. Epub 2009 Sep 16. Urology. 2009. PMID: 19758684

9

Words of wisdom. Re: Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM.

Gonzalgo ML, Parekh DJ. Gonzalgo ML, et al. Eur Urol. 2009 Sep;56(3):571-2. doi: 10.1016/j.eururo.2009.06.016. Eur Urol. 2009. PMID: 19824148 No abstract available.

10

Significance of preoperative PSA velocity in men with low serum PSA and normal DRE.

Makarov DV, Loeb S, Magheli A, Zhao K, Humphreys E, Gonzalgo ML, Partin AW, Han M. Makarov DV, et al. Among authors: gonzalgo ml. World J Urol. 2011 Feb;29(1):11-4. doi: 10.1007/s00345-010-0625-4. Epub 2010 Dec 14. World J Urol. 2011. PMID: 21153643 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters